What does Mimed Dr Bitar Ch do?

Mimed Dr Bitar Ch is a specialist medical practice in Jurbise. Private Limited, started on 22 October 2010, 1 establishment.

What is the address of Mimed Dr Bitar Ch?

The registered office of Mimed Dr Bitar Ch is located at Route d'Ath(J) 70, 7050 Jurbise.

Is Mimed Dr Bitar Ch still active?

Yes. According to the CBE (30 October 2026) Mimed Dr Bitar Ch is active, legal situation “Normale toestand”, started on 22 October 2010.

Is Mimed Dr Bitar Ch registered on Peppol?

Yes, Mimed Dr Bitar Ch is registered on the Peppol network with ID 0208:0830803812.

What is the enterprise number of Mimed Dr Bitar Ch?

The enterprise number of Mimed Dr Bitar Ch is BE0830803812.

When was Mimed Dr Bitar Ch founded?

Mimed Dr Bitar Ch was founded on 22 October 2010.

Who are the directors of Mimed Dr Bitar Ch?

According to the 2025 annual accounts, the directors of Mimed Dr Bitar Ch are: CHAALAN BITAR.

Is Mimed Dr Bitar Ch a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 22 October 2010; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Mimed Dr Bitar Ch make in 2025?

Mimed Dr Bitar Ch posted a profit after taxes of € 63,461 in financial year 2025.

What is the revenue of Mimed Dr Bitar Ch?

As a small company, Mimed Dr Bitar Ch is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 96,494.

Mimed Dr Bitar Ch (Private Limited) - Jurbise

Dossier Mimed Dr Bitar Ch, printed on 30 October 2026 from databakkes.be/en/0830803812/mimed-dr-bitar-ch. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Mimed Dr Bitar Ch from Jurbise, company number BE0830803812, closed financial year 2025 with a result of € 63,461 after tax. For that financial year Mimed Dr Bitar Ch recorded a gross margin of € 96,494 and equity of € 209,183. Compared with financial year 2024, the result moved from € 64,153 to € 63,461. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 7, 2026.

What it is worth Healthy

€ 209,183

▼ 25% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 63,461

▼ 1% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 227,378

▲ 35% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 134,535 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 1,025

▼ 62% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Taxes

€ 32,988

▲ 103% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 87,354 Gross margin 2022: € 87,354 First fiscal year in the series	€ 90,486 Gross margin 2023: € 90,486 ▲ 4% vs 2022 (€ 87,354) Favourable step	€ 100,066 Gross margin 2024: € 100,066 ▲ 11% vs 2023 (€ 90,486) Favourable step	€ 96,494 Gross margin 2025: € 96,494 ▼ 4% vs 2024 (€ 100,066) Unfavourable step	▼ 4%
Profit after taxes	€ 56,296 Profit after taxes 2022: € 56,296 First fiscal year in the series	€ 57,947 Profit after taxes 2023: € 57,947 ▲ 3% vs 2022 (€ 56,296) Favourable step	€ 64,153 Profit after taxes 2024: € 64,153 ▲ 11% vs 2023 (€ 57,947) Favourable step	€ 63,461 Profit after taxes 2025: € 63,461 ▼ 1% vs 2024 (€ 64,153) Unfavourable step	▼ 1%
Equity	€ 236,520 Equity 2022: € 236,520 First fiscal year in the series	€ 249,808 Equity 2023: € 249,808 ▲ 6% vs 2022 (€ 236,520) Favourable step	€ 280,257 Equity 2024: € 280,257 ▲ 12% vs 2023 (€ 249,808) Favourable step	€ 209,183 Equity 2025: € 209,183 ▼ 25% vs 2024 (€ 280,257) Unfavourable step	▼ 25%
Total debts	€ 65,679 Total debts 2022: € 65,679 First fiscal year in the series	€ 63,024 Total debts 2023: € 63,024 ▼ 4% vs 2022 (€ 65,679) Favourable step	€ 49,947 Total debts 2024: € 49,947 ▼ 21% vs 2023 (€ 63,024) Favourable step	€ 167,462 Total debts 2025: € 167,462 ▲ 235% vs 2024 (€ 49,947) Unfavourable step	▲ 235%
Cash	€ 64,524 Cash 2022: € 64,524 First fiscal year in the series	€ 136,125 Cash 2023: € 136,125 ▲ 111% vs 2022 (€ 64,524) Favourable step	€ 168,074 Cash 2024: € 168,074 ▲ 23% vs 2023 (€ 136,125) Favourable step	€ 227,378 Cash 2025: € 227,378 ▲ 35% vs 2024 (€ 168,074) Favourable step	▲ 35%
Land & buildings	€ 6,328 Land & buildings 2022: € 6,328 First fiscal year in the series	€ 15,863 Land & buildings 2023: € 15,863 ▲ 151% vs 2022 (€ 6,328) Unchanged	€ 14,146 Land & buildings 2024: € 14,146 ▼ 11% vs 2023 (€ 15,863) Unchanged	€ 12,429 Land & buildings 2025: € 12,429 ▼ 12% vs 2024 (€ 14,146) Unchanged	▼ 12%
Retained profit	€ 217,920 Retained profit 2022: € 217,920 First fiscal year in the series	€ 231,208 Retained profit 2023: € 231,208 ▲ 6% vs 2022 (€ 217,920) Favourable step	€ 261,657 Retained profit 2024: € 261,657 ▲ 13% vs 2023 (€ 231,208) Favourable step	€ 190,583 Retained profit 2025: € 190,583 ▼ 27% vs 2024 (€ 261,657) Unfavourable step	▼ 27%
Dividend	€ 44,396 Dividend 2022: € 44,396 First fiscal year in the series	€ 44,659 Dividend 2023: € 44,659 ▲ 1% vs 2022 (€ 44,396) Unchanged	€ 33,704 Dividend 2024: € 33,704 ▼ 25% vs 2023 (€ 44,659) Unchanged	€ 134,535 Dividend 2025: € 134,535 ▲ 299% vs 2024 (€ 33,704) Unchanged	▲ 299%
Balance sheet total	€ 302,199 Balance sheet total 2022: € 302,199 First fiscal year in the series	€ 312,833 Balance sheet total 2023: € 312,833 ▲ 4% vs 2022 (€ 302,199) Unchanged	€ 330,203 Balance sheet total 2024: € 330,203 ▲ 6% vs 2023 (€ 312,833) Unchanged	€ 376,645 Balance sheet total 2025: € 376,645 ▲ 14% vs 2024 (€ 330,203) Unchanged	▲ 14%

Key figures of Mimed Dr Bitar Ch, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Mimed Dr Bitar Ch?

What happened at Mimed Dr Bitar Ch in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 7, 2026 New annual accounts for financial year 2025: profit of € 63,461 (▼ 1% vs 2024). Source: NBB ↗
Jan 1, 2011 New establishment in Jurbise. KBO
2010 CHAALAN BITAR became a director. NBB
Oct 22, 2010 Start of the company according to the CBE. KBO

In short

From € 56,296 profit in 2022 to € 63,461 profit in 2025.

Paid € 118,750 in corporate taxes since 2022.

Best year ever: 2024, with € 64,153 profit.

Paid out € 257,293 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

CHAALAN BITAR

Mimed Dr Bitar Ch

Behind Mimed Dr Bitar Ch is CHAALAN BITAR.

Directors

According to the 2025 annual accounts

CHAALAN BITAR

Manager

since 2010

Establishments

Establishment units

Physical locations of this company

Registered office

Route d'Ath(J) 70

7050 Jurbise

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0830.803.812
VAT number: BE 0830.803.812
Registered office: Route d'Ath(J) 70, 7050 Jurbise
Names & denominations: Mimed Dr Bitar Ch
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 22 October 2010
Peppol: Active · Active since 13 Jan 2026
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗